ImmunologybioRxivPreprint
CRY-NLRP3 complexes define a circadian checkpoint controlling inflammasome activation
Léa Bardoulet, Delphine Burlet, Hubert B. Leloup…·Anne‐Laure Huber
This study identifies CRY-NLRP3 complexes as a circadian checkpoint that modulates inflammasome activation and drug response, showing time-of-day effects on inflammation and drug efficacy.
DOI 10.64898/2026.02.26.708242